Pixalate’s April 2024 Mobile App Spoofing Report For Apple App Store and Google Play Store: Solitaire Verse, 2048, Calculator Among Most at Risk
May 17, 2024 13:00 ET
|
Pixalate Inc.
LONDON, May 17, 2024 (GLOBE NEWSWIRE) -- Pixalate, the market-leading fraud protection, privacy, and compliance analytics platform for Connected TV (CTV) and Mobile Advertising, today released the...
Tevogen Bio Appoints Former Police Chief & FBI National Academy Graduate, William Keane, as Vice President of Strategic Initiatives
May 16, 2024 14:00 ET
|
Tevogen Bio Inc
Former police chief & FBI National Academy graduate, William Keane, to work with functional leads, ensure policies, procure Tevogen’s lab space.
Pixalate’s April 2024 Ad Fraud Research on Global CTV App Spoofing on Apple TV, Amazon Fire TV, Roku, & Samsung Smart TV: 8.3% of CTV App Traffic is Spoofed - TNT, Lifetime, USA Network Among Most at Risk
May 16, 2024 13:02 ET
|
Pixalate Inc.
LONDON, May 16, 2024 (GLOBE NEWSWIRE) -- Pixalate, the market-leading fraud protection, privacy, and compliance analytics platform for Connected TV (CTV) and Mobile Advertising, today released the...
The Advertising Research Foundation Unveils Findings From Attention Measurement Validation Initiative Phase Two Report
May 16, 2024 12:20 ET
|
Advertising Research Foundation
ARF released findings comparing 12 attention measurement companies at ATTENTION 2024 in New York.
Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update
May 16, 2024 09:29 ET
|
Traws Pharma, Inc.
Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update
Brain Cancer Canada Awards Grant for Innovative Medical Avatar Technology to Improve Treatments in High Grade Gliomas like Glioblastoma
May 16, 2024 08:45 ET
|
Brain Cancer Canada
TORONTO, May 16, 2024 (GLOBE NEWSWIRE) -- Brain Cancer Canada is proud to announce the awarding of a $64,000 research grant to Dr. Claire Dubois, PhD, Professor at the Université de Sherbrooke –...
AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 16, 2024 07:30 ET
|
AIM ImmunoTech Inc.
Continued execution across Ampligen® clinical development programs and growing body of positive data in multiple high-value indications Company to host conference call and webcast today, May...
Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)
May 16, 2024 06:00 ET
|
Arvinas Inc.
– After six months of additional follow-up, clinical benefit rate (63%), overall response rate (41.9%), median progression-free survival (11.2 months), and safety profile of vepdegestrant in...
Novartis meets all tender offer conditions to acquire MorphoSys AG for EUR 68 per share in cash
May 16, 2024 05:27 ET
|
Novartis Pharma AG
Novartis secured 79.6 percent acceptance by MorphoSys shareholders during the initial acceptance period, reaching the minimum 65% acceptance thresholdSettlement of the shares tendered during the...
Oncocyte Reports First Quarter 2024 Financial Results
May 15, 2024 16:05 ET
|
OncoCyte Corporation
ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS